Transthyretin: roles in the nervous system beyond thyroxine and retinol transport

References

• Seibert FB, Nelson JW. Electrophoretic study of the blood protein response in tuberculosis. J. Biol. Chem.143(1), 29–38 (1942).
   Google Scholar
• Kabat EA, Moore DH, Landow H. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J. Clin. Invest.21(5), 571–577 (1942).
   PubMedGoogle Scholar
• Nomenclature committee of IUB (NC-IUB) IUB-IUPAC Joint commission on biochemical nomenclature (JCBN). Newsletter 1981. J. Biol. Chem.256(1), 12–14 (1981).
   PubMedGoogle Scholar
• Raz A, Goodman DS. The interaction of thyroxine with human plasma prealbumin and with the prealbumin–retinol-binding protein complex. J. Biol. Chem.244(12), 3230–3237 (1969).
   PubMed Web of Science ®Google Scholar
• Power DM, Elias NP, Richardson SJ, Mendes J, Soares CM, Santos CR. Evolution of the thyroid hormone-binding protein, transthyretin. Gen. Comp. Endocrinol.119(3), 241–255 (2000).
   PubMed Web of Science ®Google Scholar
• Schreiber G, Richardson SJ. The evolution of gene expression, structure and function of transthyretin. Comp. Biochem. Physiol. B. Biochem. Mol. Biol.116(2), 137–160 (1997).
   PubMed Web of Science ®Google Scholar
• Blake CC, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol.121(3), 339–356 (1978).
   PubMed Web of Science ®Google Scholar
• Blake CC, Swan ID, Rerat C, Berthou J, Laurent A, Rerat B. An x-ray study of the subunit structure of prealbumin. J. Mol. Biol.61(1), 217–224 (1971).
   PubMed Web of Science ®Google Scholar
• Felding P, Fex G. Cellular origin of prealbumin in the rat. Biochim. Biophys. Acta716(3), 446–449 (1982).
   PubMedGoogle Scholar
• Aleshire SL, Bradley CA, Richardson LD, Parl FF. Localization of human prealbumin in choroid plexus epithelium. J. Histochem. Cytochem.31(5), 608–612 (1983).
   PubMed Web of Science ®Google Scholar
• Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J. Biol. Chem.260(21), 11793–11798 (1985).
   PubMed Web of Science ®Google Scholar
• Soprano DR, Soprano KJ, Goodman DS. Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat. Proc. Natl Acad. Sci. USA83(19), 7330–7334 (1986).
   PubMedGoogle Scholar
• Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest. Ophthalmol. Visual Sci.31(3), 497–501 (1990).
   PubMed Web of Science ®Google Scholar
• Martone RL, Schon EA, Goodman DS, Soprano DR, Herbert J. Retinol-binding protein is synthesized in the mammalian eye. Biochem. Biophys. Res. Commun.157(3), 1078–1084 (1988).
   PubMed Web of Science ®Google Scholar
• Jacobsson B, Collins VP, Grimelius L, Pettersson T, Sandstedt B, Carlstrom A. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J. Histochem. Cytochem.: Official J. Histochem. Soc.37(1), 31–37 (1989).
   PubMed Web of Science ®Google Scholar
• Martone RL, Mizuno R, Herbert J. The mammalian pineal gland is a synthetic site for TTR and RBP. J. Rheumatol.20, 175 (1993).
   Google Scholar
• McKinnon B, Li H, Richard K, Mortimer R. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J. Clin. Endocrinol. Metab.90(12), 6714–6720 (2005).
   PubMed Web of Science ®Google Scholar
• Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJ, Blaner WS, Goodman DS. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J. Biol. Chem.263(18), 8598–8603 (1988).
   PubMed Web of Science ®Google Scholar
• Sousa MM, Saraiva MJ. Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J. Biol. Chem.276(17), 14420–14425 (2001).
   PubMed Web of Science ®Google Scholar
• Sousa MM, Norden AG, Jacobsen C et al. Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem.275(49), 38176–38181 (2000).
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, De Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet2(7768), 106–109 (1972).
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, Van Den Schrieck HG, De Nayer P, De Visscher M. Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition. Clin. Chim. Acta63(1), 61–67 (1975).
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, Young VR. Significance of transthyretin in protein metabolism. Clin. Chem. Lab. Med.40(12), 1281–1291 (2002).
   PubMed Web of Science ®Google Scholar
• Potter MA, Luxton G. Transthyretin measurement as a screening tool for protein calorie malnutrition in emergency hospital admissions. Clin. Chem. Lab Med.40, 1349–1354 (2002).
   Google Scholar
• Ingenbleek Y. Plasma transthyretin reflects the fluctuations of lean body mass in health and disease. In: Recent Advances in Transthyretin Evolution, Structure and Biological Functions. Richardson SJ, Cody V (Eds). Springer-Verlag, Berlin Heidelberg, Germany (2009).
   Google Scholar
• Dentice M, Salvatore D. Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J. Endocrinol.209(3), 273–282 (2011).
   PubMed Web of Science ®Google Scholar
• Bartalena L. Recent achievements in studies on thyroid hormone-binding proteins. Endocrine Rev.11(1), 47–64 (1990).
   PubMed Web of Science ®Google Scholar
• Hagen GA, Solberg LA Jr. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology95(5), 1398–1410 (1974).
   PubMed Web of Science ®Google Scholar
• Chanoine JP, Braverman LE. The role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brain. Acta Med. Austriaca19(Suppl. 1), 25–28 (1992).
   PubMedGoogle Scholar
• Andrea TA, Cavalieri RR, Goldfine ID, Jorgensen EC. Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry19(1), 55–63 (1980).
   PubMed Web of Science ®Google Scholar
• Palha JA. Transthyretin as a thyroid hormone carrier: function revisited. Clin. Chem. Lab Med.40(12), 1292–1300 (2002).
   PubMed Web of Science ®Google Scholar
• Episkopou V, Maeda S, Nishiguchi S et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl Acad. Sci. USA90(6), 2375–2379 (1993).
   PubMed Web of Science ®Google Scholar
• Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJ. Thyroid hormone metabolism in a transthyretin-null mouse strain. J. Biol. Chem.269(52), 33135–33139 (1994).
   PubMedGoogle Scholar
• Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocrine Rev.10(3), 232–274 (1989).
   PubMed Web of Science ®Google Scholar
• Palha JA, Fernandes R, De Escobar GM, Episkopou V, Gottesman M, Saraiva MJ. Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology141(9), 3267–3272 (2000).
   PubMed Web of Science ®Google Scholar
• Palha JA, Hays MT, Morreale De Escobar G, Episkopou V, Gottesman ME, Saraiva MJ. Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice. Am. J. Physiol.272(3 Pt 1), E485–E493 (1997).
   Google Scholar
• Palha JA, Nissanov J, Fernandes R et al. Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience113(4), 837–847 (2002).
   PubMed Web of Science ®Google Scholar
• Kallee E, Ott H. Albuminpolymorphien: analbuminaemie, bisalbuminaemie und dysalbuminaemische hyperthyroxinaemie. In: Innere Medizin in Praxis und Klinik. Hornbostel H, Kaufmann W, Siegenthaler W (Eds). Georg Thieme Verlag Stuttgart, New York, USA, 108–119 (1992).
   Google Scholar
• Mendel CM, Murai JT, Siiteri PK, Monroe SE, Inoue M. Conservation of free but not total or non-sex-hormone-binding-globulin-bound testosterone in serum from Nagase analbuminemic rats. Endocrinology124(6), 3128–3130 (1989).
   PubMedGoogle Scholar
• Bartalena L. Studies on thyroxine-binding globulin. J. Endocrinol. Invest.16(5), 353–371 (1993).
   PubMedGoogle Scholar
• Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocrine Rev.10(3), 275–293 (1989).
   PubMed Web of Science ®Google Scholar
• Kassem NA, Deane R, Segal MB, Preston JE. Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus. Am. J. Physiol.291(5), R1310–R1315 (2006).
   Google Scholar
• Landers KA, McKinnon BD, Li H, Subramaniam VN, Mortimer RH, Richard K. Carrier-mediated thyroid hormone transport into placenta by placental transthyretin. J. Clin. Endocrinol. Metab.94(7), 2610–2616 (2009).
   PubMedGoogle Scholar
• Patel J, Landers K, Li H, Mortimer RH, Richard K. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol. Metab.22(5), 164–170 (2011).
   PubMed Web of Science ®Google Scholar
• Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J. Clin. Invest.47(9), 2025–2044 (1968).
   PubMed Web of Science ®Google Scholar
• Gudas LJ. Emerging roles for retinoids in regeneration and differentiation in normal and disease states. Biochim. Et Biophys. Acta (2011).
   PubMedGoogle Scholar
• Goodman DS. Vitamin A and retinoids in health and disease. N. Engl. J. Med.310(16), 1023–1031 (1984).
   PubMed Web of Science ®Google Scholar
• Noy N, Slosberg E, Scarlata S. Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin. Biochemistry31(45), 11118–11124 (1992).
   PubMedGoogle Scholar
• van Bennekum AM, Wei S, Gamble MV et al. Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. J. Biol. Chem.276(2), 1107–1113 (2001).
   PubMed Web of Science ®Google Scholar
• Monaco HL, Rizzi M, Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science268(5213), 1039–1041 (1995).
   PubMed Web of Science ®Google Scholar
• Wei S, Episkopou V, Piantedosi R et al. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J. Biol. Chem.270(2), 866–870 (1995).
   PubMedGoogle Scholar
• Sundaram M, Sivaprasadarao A, Desousa MM, Findlay JB. The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J. Biol. Chem.273(6), 3336–3342 (1998).
   PubMedGoogle Scholar
• Kawaguchi R, Yu J, Honda J et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science315(5813), 820–825 (2007).
   PubMed Web of Science ®Google Scholar
• Sousa MM, Berglund L, Saraiva MJ. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res.41(1), 58–65 (2000).
   PubMed Web of Science ®Google Scholar
• Liz MA, Faro CJ, Saraiva MJ, Sousa MM. Transthyretin, a new cryptic protease. J. Biol. Chem.279(20), 21431–21438 (2004).
   PubMed Web of Science ®Google Scholar
• Liz MA, Gomes CM, Saraiva MJ, Sousa MM. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res.48(11), 2385–2395 (2007).
   PubMed Web of Science ®Google Scholar
• Liz MA, Fleming CE, Nunes AF et al. Substrate specificity of transthyretin: identification of natural substrates in the nervous system. Biochem. J.419(2), 467–474 (2009).
   PubMed Web of Science ®Google Scholar
• Costa R, Ferreira-Da-Silva F, Saraiva MJ, Cardoso I. Transthyretin protects against A-β peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One3(8), e2899 (2008).
   PubMed Web of Science ®Google Scholar
• Sousa JC, Grandela C, Fernandez-Ruiz J et al. Transthyretin is involved in depression-like behaviour and exploratory activity. J. Neurochem.88(5), 1052–1058 (2004).
   PubMed Web of Science ®Google Scholar
• Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides38(4), 213–224 (2004).
   PubMed Web of Science ®Google Scholar
• Nunes AF, Saraiva MJ, Sousa MM. Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J.20(1), 166–168 (2006).
   PubMedGoogle Scholar
• Fleming CE, Saraiva MJ, Sousa MM. Transthyretin enhances nerve regeneration. J. Neurochem.103(2), 831–839 (2007).
   PubMed Web of Science ®Google Scholar
• Brouillette J, Quirion R. Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol. Aging29(11), 1721–1732 (2008).
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Ye Z, Reixach N et al. Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Aβ toxicity. Proc. Natl Acad. Sci. USA105(7), 2681–2686 (2008).
   PubMed Web of Science ®Google Scholar
• Sousa JC, Marques F, Dias-Ferreira E, Cerqueira JJ, Sousa N, Palha JA. Transthyretin influences spatial reference memory. Neurobiol. Learn. Mem.88(3), 381–385 (2007).
   PubMedGoogle Scholar
• Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell. Mol. Life Sci.57(8–9), 1236–1259 (2000).
   PubMed Web of Science ®Google Scholar
• Fleming CE, Mar FM, Franquinho F, Saraiva MJ, Sousa MM. Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci.: Official J. Soc. Neurosci.29(10), 3220–3232 (2009).
   PubMed Web of Science ®Google Scholar
• Liverman CS, Cui L, Yong C et al. Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization. Brain Res. Mol. Brain Res.126(1), 57–66 (2004).
   PubMedGoogle Scholar
• Suzuyama K, Shiraishi T, Oishi T et al. Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Brain Res. Mol. Brain Res.129(1–2), 44–53 (2004).
   PubMedGoogle Scholar
• Sironi L, Tremoli E, Miller I et al. Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics. Stroke32(3), 753–760 (2001).
   PubMed Web of Science ®Google Scholar
• Santos SD, Lambertsen KL, Clausen BH et al. CSF transthyretin neuroprotection in a mouse model of brain ischemia. J. Neurochem.115(6), 1434–1444 (2010).
   PubMedGoogle Scholar
• Wang X, Li W, Zhao D et al.Caenorhabditis elegans transthyretin-like protein TTR-52 mediates recognition of apoptotic cells by the CED-1 phagocyte receptor. Nat. Cell Biol.12(7), 655–664 (2010).
   PubMedGoogle Scholar
• Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science314(5800), 777–781 (2006).
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science297(5580), 353–356 (2002).
   PubMed Web of Science ®Google Scholar
• Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH. Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis. J. Neurosci.: Official J. Soc. Neurosci.30(45), 14946–14954 (2010).
   PubMed Web of Science ®Google Scholar
• Schwarzman AL, Gregori L, Vitek MP et al. Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl Acad. Sci. USA91(18), 8368–8372 (1994).
   PubMed Web of Science ®Google Scholar
• Liu L, Murphy RM. Kinetics of inhibition of β-amyloid aggregation by transthyretin. Biochemistry45(51), 15702–15709 (2006).
   PubMedGoogle Scholar
• Costa R, Goncalves A, Saraiva MJ, Cardoso I. Transthyretin binding to A-B peptide – impact on A-B fibrillogenesis and toxicity. FEBS Lett.582(6), 936–942 (2008).
   PubMedGoogle Scholar
• Stein TD, Anders NJ, Decarli C, Chan SL, Mattson MP, Johnson JA. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J. Neurosci.24(35), 7707–7717 (2004).
   PubMed Web of Science ®Google Scholar
• Stein TD, Johnson JA. Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity. Rev. Neurosci.14(4), 317–341 (2003).
   PubMedGoogle Scholar
• Castaño EM, Roher AE, Esh CL, Kokjohn TA, Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer’s disease and non-demented elderly subjects. Neurol. Res.28(2), 155–163 (2006).
   PubMed Web of Science ®Google Scholar
• Gloeckner SF, Meyne F, Wagner F et al. Quantitative analysis of transthyretin, tau and amyloid-β in patients with dementia. J. Alzheimers Dis.14(1), 17–25 (2008).
   PubMedGoogle Scholar
• Serot JM, Christmann D, Dubost T, Couturier M. Cerebrospinal fluid transthyretin: aging and late onset al z.heimer’s disease. J. Neurol. Neurosurg. Psychiat.63(4), 506–508 (1997).
   PubMed Web of Science ®Google Scholar
• Riisoen H. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer’s disease. Acta Neurol. Scand.78(6), 455–459 (1988).
   PubMed Web of Science ®Google Scholar
• Merched A, Serot JM, Visvikis S, Aguillon D, Faure G, Siest G. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer’s patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett425(2), 225–228 (1998).
   PubMed Web of Science ®Google Scholar
• Han SH, Jung ES, Sohn JH et al. Human serum transthyretin levels correlate inversely with Alzheimer’s disease. J. Alzheimers Dis.25(1), 77–84 (2011).
   PubMed Web of Science ®Google Scholar
• Oliveira SM, Ribeiro CA, Cardoso I, Saraiva MJ. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer’s disease. J. Alzheimers Dis.27(2), 429–439 (2011).
   PubMed Web of Science ®Google Scholar
• Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of transthyretin in human and murine Alzheimer’s disease: is it protective? J. Neurosci.: Official J. Soc. Neurosci.31(35), 12483–12490 (2011).
   PubMed Web of Science ®Google Scholar
• Lazarov O, Robinson J, Tang YP et al. Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell120(5), 701–713 (2005).
   PubMed Web of Science ®Google Scholar
• Choi SH, Leight SN, Lee VM et al. Accelerated Aβ deposition in APPswe/PS1ΔE9 mice with hemizygous deletions of TTR (transthyretin). J. Neurosci.27(26), 7006–7010 (2007).
   PubMed Web of Science ®Google Scholar
• Wati H, Kawarabayashi T, Matsubara E et al. Transthyretin accelerates vascular Aβ deposition in a mouse model of Alzheimer’s disease. Brain Pathol.19(1), 48–57 (2009).
   PubMedGoogle Scholar
• Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R. Possible involvement of transthyretin in hippocampal β-amyloid burden and learning behaviors in a mouse model of Alzheimer’s disease (TgCRND8). Neurodegener Dis.7(1–3), 88–95 (2010).
   PubMedGoogle Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain75(3), 408–427 (1952).
   PubMed Web of Science ®Google Scholar
• Coimbra A, Andrade C. Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes. Brain94(2), 207–212 (1971).
   PubMedGoogle Scholar
• Yamashita T, Ando Y, Uchino M. Familial amyloid polyneuropathy. Brain Nerve63(6), 583–595 (2011).
   PubMedGoogle Scholar
• Kitchens WH. Domino liver transplantation: indications, techniques, and outcomes. Transplant. Rev. (Orlando)25(4), 167–177 (2011).
   PubMedGoogle Scholar
• Almeida MR, Macedo B, Cardoso I et al. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem. J.381(Pt 2), 351–356 (2004).
   PubMed Web of Science ®Google Scholar
• Cardoso I, Almeida MR, Ferreira N, Arsequell G, Valencia G, Saraiva MJ. Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design. Biochem. J.408(1), 131–138 (2007).
   PubMedGoogle Scholar
• Ferreira N, Cardoso I, Domingues MR et al. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity. FEBS Lett.583(22), 3569–3576 (2009).
   PubMed Web of Science ®Google Scholar
• Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC. Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol.7(4), 312–321 (2000).
   PubMedGoogle Scholar
• Macedo B, Magalhaes J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol. Res.62(6), 514–522 (2010).
   PubMed Web of Science ®Google Scholar
• Oza VB, Smith C, Raman P et al. Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. J. Med. Chem.45(2), 321–332 (2002).
   PubMed Web of Science ®Google Scholar
• Trivella DB, Bleicher L, Palmieri Lde C et al. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding. J. Struct. Biol.170(3), 522–531 (2010).
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des.14(30), 3219–3230 (2008).
   PubMed Web of Science ®Google Scholar
• Cardoso I, Merlini G, Saraiva MJ. 4’-iodo-4’-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. FASEB J.17(8), 803–809 (2003).
   PubMed Web of Science ®Google Scholar
• Cardoso I, Saraiva MJ. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model. FASEB J.20(2), 234–239 (2006).
   PubMed Web of Science ®Google Scholar
• Macedo B, Batista AR, Ferreira N, Almeida MR, Saraiva MJ. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Biochim. Et Biophys. Acta1782(9), 517–522 (2008).
   PubMed Web of Science ®Google Scholar
• Cardoso I, Martins D, Ribeiro T, Merlini G, Saraiva MJ. Synergy of combined doxycycline/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse models. J. Transl. Med.8, 74 (2010).
   PubMed Web of Science ®Google Scholar
• Terazaki H, Ando Y, Fernandes R, Yamamura K, Maeda S, Saraiva MJ. Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Lab Invest.86(1), 23–31 (2006).
   PubMed Web of Science ®Google Scholar
• Love KT, Mahon KP, Levins CG et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA107(5), 1864–1869 (2010).
   PubMed Web of Science ®Google Scholar